IntelGenx Corp. Security Holders Approved the Amendment of the 2006 Stock Option Plan

SAINT LAURENT, QUEBEC--(Marketwire - September 24, 2010) - IntelGenx Technologies Corp. (TSX VENTURE: IGX)(OTCBB: IGXT) (“IntelGenx” or the “Company”) announced today that at the Company’s Annual General Meeting on June 3, 2010, the Security Holders of the Company approved to amend the 2006 Stock Option Plan to increase the number of shares available for issuance under the Plan from 2,074,000 to 3,308,127, or 10% of the Company’s issued and outstanding shares. The amendment of the Plan is subject to TSX-Venture approval.

About IntelGenx Corp.

IntelGenx Corp. is a drug delivery company focused on the development of oral controlled-release products as well as novel rapidly disintegrating delivery systems. IntelGenx uses its unique multiple layer delivery system to provide zero-order release of active drugs in the gastrointestinal tract. IntelGenx has also developed novel delivery technologies for the rapid delivery of pharmaceutically active substances in the oral cavity based on its experience with rapidly disintegrating films. IntelGenx’ research and development pipeline includes products for the treatment of pain, hypertension, erectile dysfunction and depressive disorders. More information is available about the company at www.intelgenx.com.

Each of the TSX Venture Exchange and OTC Bulletin Board has neither approved nor disapproved the contents of this press release.